UPDATE 3-Sage soars as postpartum depression drug moves closer to approval
November 09, 2017 at 10:26 AM EST
* Shares zoom about 55 pct to all-time high (Adds details from conference call, analyst comments and background on disease space)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|